UPPER RESP TRACT INFECTION
Clinical trials for UPPER RESP TRACT INFECTION explained in plain language.
Never miss a new study
Get alerted when new UPPER RESP TRACT INFECTION trials appear
Sign up with your email to follow new studies for UPPER RESP TRACT INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug fights common cold to protect vulnerable lungs
Disease control CompletedThis study tested an experimental drug called vapendavir to see if it could reduce serious lung symptoms in people with COPD after they caught a common cold virus. Researchers gave the drug or a placebo to 52 adults with moderate COPD who were then exposed to the virus. The main …
Matched conditions: UPPER RESP TRACT INFECTION
Phase: PHASE2 • Sponsor: Altesa Biosciences, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Cough cure showdown: which medicine really works?
Symptom relief CompletedThis study tested three common cough medicines against a placebo to see which works best for adults with colds. 184 adults with moderate to severe coughs took either levodropropizine, codeine combination, ivy leaf extract, or a dummy pill for 4 days. Researchers measured how quic…
Matched conditions: UPPER RESP TRACT INFECTION
Phase: PHASE4 • Sponsor: Pontificia Universidad Catolica de Chile • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC